Squamous dedifferentiation and differentiated high-grade transformation of papillary thyroid carcinoma in metastatic lymph nodes: Two cases and literature review Authors: Abdulwahid M. Salih, Rawa M. Ali, Ari M. Abdullah, Imad J. Habibullah, Zuhair D. Hammood, Meer M. Abdulkarim, Abdullah A. Qadir, Harun Amanj Ahmed, Shko H. Hassan, Fahmi H. Kakamad Published: 2026 ABSTRACT Although it is extremely rare, papillary thyroid carcinoma (PTC) can exhibit unexpected behavior, with the potential to transform into more lethal forms in metastatic sites. This report describes 2 cases in which PTC transformed within metastatic lymph nodes. Case 1: A 57-year-old woman with a progressively enlarging right neck mass was found on imaging to have cervical lymphadenopathy and small right thyroid nodules. She underwent total thyroidectomy with neck dissection. Histopathology revealed metastatic PTC with squamous dedifferentiation in cervical nodes. Immunohistochemistry confirmed thyroid origin.Case 2: A 45-year-old woman presented with right submandibular swelling. Ultrasound revealed a left thyroid nodule with suspicious cervical lymphadenopathy. She underwent total thyroidectomy with neck dissection. Histopathology showed conventional PTC with high-grade transformation in 1 metastatic lymph node, consistent with differentiated high-grade thyroid carcinoma. Seven cases of PTC transformation in metastatic sites were reviewed. Ages ranged from 56 to 79 years. Symptoms were neck masses, respiratory, and systemic symptoms. Most cases were conventional PTC. Transformation predominantly resulted in squamous cell carcinoma, though rarer transformations were present. The transformations were mainly regional, but distant metastatic sites such as the lung were also reported. Management included total thyroidectomy and neck dissections with radioactive iodine, often combined with chemoradiation or targeted therapy for advanced cases. Lymph node metastases originating from the thyroid may undergo histological transformation and exhibit aggressive behavior. Total thyroidectomy combined with radioiodine ablation and hormone therapy might yield favorable outcomes, but regional and distant metastases may still develop. Introduction Thyroid cancer represents a significant global health concern, with an estimated 821,000 new cases reported in 2022. It accounts for approximately 4.1% of all newly diagnosed cancers, making it the seventh most common malignancy worldwide [1]. Several factors have been associated with an increased risk of thyroid cancer, including Hashimoto’s thyroiditis and genetic syndromes such as multiple endocrine neoplasia type 2, Carney complex, Werner syndrome, and DICER1 syndrome [2]. Papillary thyroid carcinoma (PTC) is the most common form of thyroid malignancy and is generally associated with a favorable prognosis. Its subtypes include classic, follicular, solid, and diffuse sclerosing variants, with reported incidence ranging from 3.2% to 19%, depending on population and diagnostic criteria [2,3]. Certain PTC subtypes may undergo dedifferentiation, resulting in more aggressive behavior, loss of iodide uptake, accelerated disease progression, and increased mortality [1]. Squamoid elements are relatively common in PTC, observed in up to 40% of cases, and are thought to result from metaplastic change. In contrast, true coexisting squamous cell carcinoma (SCC) is rare [4]. The origin of these lesions remains controversial: some authors consider them collision tumors arising independently, while others propose that the SCC component represents dedifferentiation of the underlying PTC [4]. Differentiated high-grade thyroid carcinoma (DHGTC) was formally recognized in the fifth edition of the World Health Organization classification of endocrine tumors released in late 2022 [5]. Although its exact prevalence is uncertain, DHGTC is a rare condition, maintaining the structural and cytological features of well-differentiated tumors while exhibiting high-grade characteristics [5]. Based on the available literature, the transformation of PTC into DHGTC within a metastatic lymph node has not been previously reported. This report presents 2 cases of PTC transforming into SCC and DHGTC in metastasized lymph nodes. This report was written in accordance with the CaReL guideline, and all references were checked for validity [6,7]. Case presentations Case 1 Patient information A 57-year-old female presented with a right-sided neck swelling persisting for 1 month. Her medical history included hypertension, diabetes mellitus, and ischemic heart disease, and her surgical history included a cesarean section. Clinical findings On examination, she was hemodynamically stable. The thyroid gland was enlarged (Grade 2-3) with associated cervical lymphadenopathy. The swelling had been progressively increasing over the past 8 months and was painless. Diagnostic approach Thyroid-stimulating hormone was 3.0 mIU/L (normal range: 0.4-4.0 mIU/L), and thyroglobulin was 24 ng/mL (normal range: 3.5-77 ng/mL). Neck ultrasound (US) revealed a suspicious solid hypoechoic mass in the right lower anterior triangle, extending mildly retroclavicularly, measuring 38 × 31 × 31 mm, with peripheral vascularity and signs of local tissue invasion. The mass mildly compressed the right common carotid artery and internal jugular vein, raising high suspicion for a malignant lymph node or metastatic lesion. Multiple bilateral cervical lymph nodes were noted, predominantly on the right, with the largest measuring 17 × 6 mm in right group II and 13 × 4 mm in left group III. Several nodes demonstrated altered morphology, including loss of normal hilum and distorted shape, suggestive of metastatic involvement. The thyroid gland contained a 5 × 4 × 3 mm solid hypoechoic nodule of Thyroid Imaging Reporting and Data System (TIRADS) score of 4 with central macrocalcification in the right mid-lobe, and a 3 × 4 × 2 mm TIRADS 4 nodule near the right isthmus. Computed tomography of the neck, chest, and abdomen identified a right supraclavicular mass and a paratracheal nodule, likely to represent an exophytic right thyroid primary with metastatic supraclavicular lymphadenopathy, local extension, and vascular encasement. US-guided fine-needle aspiration (FNA) of the suspicious lymph node confirmed metastatic PTC in the right supraclavicular lymph node (Fig. 1).Fig. 1Neck CT with intravenous contrast. (A) Coronal section and (B) axial section demonstrating a lobulated, heterogeneously enhancing mass in the right anterior lower neck and right supraclavicular region (white arrow), suggestive of a pathological lymph node. An additional small suspicious lesion is noted on the right side of the trachea (yellow arrow), inferior to the thyroid gland (green arrow), which may represent either a pathological lymph node or an exophytic thyroid mass.Fig 1 dummy alt text Neck CT with intravenous contrast. (A) Coronal section and (B) axial section demonstrating a lobulated, heterogeneously enhancing mass in the right anterior lower neck and right supraclavicular region (white arrow), suggestive of a pathological lymph node. An additional small suspicious lesion is noted on the right side of the trachea (yellow arrow), inferior to the thyroid gland (green arrow), which may represent either a pathological lymph node or an exophytic thyroid mass. Therapeutic intervention Under general anesthesia, she underwent total thyroidectomy with right lateral and central neck dissection via a collar incision. Both recurrent laryngeal nerves and parathyroid glands were preserved. Hemostasis was achieved, and the wound was closed in layers. She remained stable postoperatively with no complications. Histopathological examination (HPE) revealed metastatic papillary thyroid carcinoma with squamous dedifferentiation in the right lateral cervical lymph nodes, with no identifiable primary tumor in the thyroid gland (Fig. 2). Immunohistochemistry demonstrated strong nuclear positivity for TTF-1 and PAX8, confirming thyroid origin, and negativity for ER and WT1, excluding mimickers. Of the 33 lymph nodes dissected, 3 showed metastases: 1/9 right central and 2/23 right lateral cervical nodes, with extensive extra-nodal extension (Fig. 3). Levothyroxine (100 μg daily) was prescribed. She was subsequently referred for radioactive iodine ablation.Fig. 2(A) The metastatic deposit demonstrates 2 distinct components: an upper component (arrows) composed of complex papillary structures, and a lower component (stars) consisting of solid sheets of malignant squamous cells. 10x (B) Another area of the lymph node shows preserved benign lymphoid tissue (stars) with admixed complex papillary structures lined by epithelial cells exhibiting oval nuclei and intranuclear pseudo-inclusions (arrows). 10x (C) A different region of the metastatic focus reveals solid sheets of malignant epithelial cells with prominent keratin pearl formation (arrows). 10x.Fig 2 dummy alt textFig. 3(A) PAX8 immunostaining demonstrates strong nuclear positivity in the papillary component (arrows), while the squamous component remains negative (stars). 10x (B) TTF-1 immunostaining shows nuclear positivity confined to the papillary areas (arrows) with absence of staining in the squamous areas (stars). 10x.Fig 3 dummy alt text (A) The metastatic deposit demonstrates 2 distinct components: an upper component (arrows) composed of complex papillary structures, and a lower component (stars) consisting of solid sheets of malignant squamous cells. 10x (B) Another area of the lymph node shows preserved benign lymphoid tissue (stars) with admixed complex papillary structures lined by epithelial cells exhibiting oval nuclei and intranuclear pseudo-inclusions (arrows). 10x (C) A different region of the metastatic focus reveals solid sheets of malignant epithelial cells with prominent keratin pearl formation (arrows). 10x. (A) PAX8 immunostaining demonstrates strong nuclear positivity in the papillary component (arrows), while the squamous component remains negative (stars). 10x (B) TTF-1 immunostaining shows nuclear positivity confined to the papillary areas (arrows) with absence of staining in the squamous areas (stars). 10x. Follow-up and outcome At the 3-month postoperative follow-up, a positron emission tomography scan revealed no evidence of recurrence in the thyroidectomy bed. However, multiple right-sided regional lymphadenopathies and extra-regional metastatic lymph nodes were identified, with additional liver involvement. The patient was referred to an oncologist and underwent 33 sessions of radiotherapy and 12 cycles of chemotherapy. At the 7-month follow-up, the patient had developed lung metastases and subsequently died. Case 2 Patient information A 45-year-old female presented with right submandibular swelling. She had a past surgical history of 2 cesarean sections. She had no significant past medical history and no relevant family history. Clinical findings On physical examination, mildly tender left cervical lymphadenopathy was noted, with other systemic examinations unremarkable. Her vital signs were stable, and there was no evidence of thyroid enlargement or local compressive symptoms. Diagnostic approach Thyroid-stimulating hormone was 2.00 mIU/L (normal range: 0.4-4.0 mIU/L), and free thyroxine was 11.2 pmol/L (normal range: 12.0-22.0 pmol/L). Serum calcium level was slightly elevated (9.61 mg/dL) (normal range: 8.2-9.6 mg/dl). Thyroglobulin was 24.0 ng/mL (normal range: 3.5-77 ng/mL), and calcitonin was < 0.5 pg/mL (normal range: < 9.82 pg/mL). Inflammatory markers were mildly elevated, including white blood cell count at 11.4 × 10⁹/L (normal range: 4.5-11×109/L) and C-reactive protein at 13.2 mg/L (normal range: < 5.0 mg/L). Neck US of the right submandibular swelling showed a reactive or inflammatory lymph node measuring 31 × 10 mm without other significant right-sided lymphadenopathies. On the left side, multiple highly suspicious lymph nodes were identified in levels II, III, and IV, characterized by loss of the fatty hilum, solid hypoechoic echotexture, and increased vascularity, with the largest measuring 25 × 12 mm in level III. Both thyroid lobes were normal in size but exhibited inhomogeneous echotexture with multiple small, solid, isoechoic nodules less than 8 mm, classified as TIRADS 3. A solid hypoechoic nodule measuring 13 × 9 × 10 mm was seen at the junction of the mid-to-lower third of the left lobe and isthmus. It had an irregular surface, contained microcalcifications, and demonstrated increased peri- and intra-nodular vascularity, along with anterior capsular irregularity and microcalcification extension beyond the capsule, suggesting possible extrathyroidal invasion. The nodule was classified as TIRADS 5. Multiple bilateral central compartment lymph nodes were also visualized, the largest measuring 18 × 10 mm near the lower pole of the left lobe, appearing highly suspicious. US-guided FNA was performed on the left TIRADS 5 thyroid nodule and the left level III lymph node. Cytology confirmed PTC (Bethesda Category VI) in the thyroid nodule and metastatic PTC in the left cervical lymph node. Therapeutic intervention Preoperative evaluation demonstrated normal bilateral vocal cord mobility. Under general anesthesia, she underwent total thyroidectomy with left lateral and bilateral central neck dissection through a collar incision. Both recurrent laryngeal nerves and parathyroid glands were preserved. Hemostasis was achieved, and the wound was closed in layers. Postoperatively, she remained stable with no complications. Histopathological examination revealed a well-differentiated Papillary Thyroid Carcinoma of the conventional type, with high-grade transformation identified in one of the metastatic lymph nodes, characterized by necrosis and increased mitotic activity (3 per 2 mm²), consistent with the diagnosis of DHGTC (Fig. 4). Immunohistochemistry was not performed, as the histopathological features were straightforward and diagnostic. Of the 74 dissected lymph nodes, 35 showed metastatic involvement with extra-nodal extension. Postoperatively, she remained hemodynamically stable and was commenced on levothyroxine 100 µg daily. Serum calcium level was 9.08 mg/dL (normal range: 8.2-9.6 mg/dL). She subsequently received radioactive iodine ablation to eliminate possible microscopic residual disease and to support long-term follow-up through thyroglobulin monitoring.Fig. 4(A) Section from the thyroid nodule shows complex papillary structures lined by follicular epithelial cells exhibiting characteristic nuclear features of papillary thyroid carcinoma (green arrows), with associated psammoma bodies (dark arrows). Hematoxylin and eosin stain, 10x. (B) Section from 1 lymph node demonstrates benign lymphoid tissue (dark stars) with an adjacent metastatic deposit (dark arrows), without high-grade histologic features. Hematoxylin and eosin stain, 10x. (C) Another lymph node reveals malignant epithelial cells arranged in papillary structures and follicles (dark arrows), with focal areas of necrosis (dark stars). Hematoxylin and eosin stain, 10x.Fig 4 dummy alt text (A) Section from the thyroid nodule shows complex papillary structures lined by follicular epithelial cells exhibiting characteristic nuclear features of papillary thyroid carcinoma (green arrows), with associated psammoma bodies (dark arrows). Hematoxylin and eosin stain, 10x. (B) Section from 1 lymph node demonstrates benign lymphoid tissue (dark stars) with an adjacent metastatic deposit (dark arrows), without high-grade histologic features. Hematoxylin and eosin stain, 10x. (C) Another lymph node reveals malignant epithelial cells arranged in papillary structures and follicles (dark arrows), with focal areas of necrosis (dark stars). Hematoxylin and eosin stain, 10x. Follow-up and outcome Follow-up neck ultrasound demonstrated a clear operative bed, with no signs of residual or recurrent disease, and suppressed thyroglobulin. At her most recent follow-up in March 2026, more than a year after her presentation, she remained clinically well. Discussion According to the fifth edition of the World Health Organization classification of thyroid neoplasms, squamous cell differentiation arising in differentiated thyroid carcinoma is categorized as a subtype of anaplastic thyroid carcinoma [8]. Anaplastic transformation typically occurs within the thyroid gland or regional cervical lymph nodes. The differential diagnosis of thyroid SCC includes primary thyroid SCC, metastatic disease from head and neck cancers, and direct invasion from adjacent structures [9]. Seven instances of tumor transformation were reviewed, 5 of which transformed into SCC (Table 1) [3,4,[8], [9], [10], [11], [12]]. Among these 5 cases, 2 occurred at distant sites [4,11].Table 1Review of papillary thyroid carcinoma transforming in metastatic sites.Table 1 – dummy alt textStudyAge/sexPresentationPTC subtypeDedifferentiated componentMetastatic site that underwent transformationTreatmentOutcomeFollow-up (months)Basnet et al. [3]56/MMultiple enlarged cervical lymph nodes; fatigue and weight lossTCVSquamous cell carcinomaRight paratracheal lymph node, left thyroid bedTotal thyroidectomy, neck dissections, RAI, chemo-radiation (carboplatin + paclitaxel)Near-complete resolution of metabolic activity3 moAcosta & Pins [4]63/MLung massConventionalSquamous cell carcinomaLungLobectomyN/AN/ALyu et al. [8]63/MRapidly growing neck massConventionalSquamous cell carcinomaCervical lymph nodesTotal thyroidectomy, neck dissection, planned chemoradiotherapyDeath due to sepsis from pneumoniaN/AIjaz & Yin [9]76/MDysphagia, weight loss, hoarseness, hemoptysisConventionalSquamous cell carcinomaPyriform sinus and peritracheal lymph nodesOpen tracheostomySeptic shockN/AXu et al. [10]78/FChest tightness, shortness of breath, coughConventionalDedifferentiated with atypical morphologyLung and pleuraCervical lymph node dissection, targeted therapy (dabrafenib, anlotinib), multiple doses of 131IDeath due to respiratory failure3 moThewjitcharoen et al. [11]79/FHoarseness, neck massConventionalSquamous cell carcinomaCervical lymph nodesRadical neck dissection, high-dose radioactive iodine, external beam radiation, tracheostomyRecurrence18 moGhosh et al. [12]62/FPulmonary and mediastinal disease, and a peripancreatic massConventionalHigh-grade mucoepidermoid carcinoma with squamous, adenocarcinoma, and anaplastic carcinoma areasLung, mediastinal lymph nodes, peripancreatic regionDabrafenib and trametinibDeathN/AAbbreviations: F, female; M, male; N/A, not applicable; PTC, papillary thyroid carcinoma; TCV, tall cell variant. Table 1Review of papillary thyroid carcinoma transforming in metastatic sites.Table 1 – dummy alt textStudyAge/sexPresentationPTC subtypeDedifferentiated componentMetastatic site that underwent transformationTreatmentOutcomeFollow-up (months)Basnet et al. [3]56/MMultiple enlarged cervical lymph nodes; fatigue and weight lossTCVSquamous cell carcinomaRight paratracheal lymph node, left thyroid bedTotal thyroidectomy, neck dissections, RAI, chemo-radiation (carboplatin + paclitaxel)Near-complete resolution of metabolic activity3 moAcosta & Pins [4]63/MLung massConventionalSquamous cell carcinomaLungLobectomyN/AN/ALyu et al. [8]63/MRapidly growing neck massConventionalSquamous cell carcinomaCervical lymph nodesTotal thyroidectomy, neck dissection, planned chemoradiotherapyDeath due to sepsis from pneumoniaN/AIjaz & Yin [9]76/MDysphagia, weight loss, hoarseness, hemoptysisConventionalSquamous cell carcinomaPyriform sinus and peritracheal lymph nodesOpen tracheostomySeptic shockN/AXu et al. [10]78/FChest tightness, shortness of breath, coughConventionalDedifferentiated with atypical morphologyLung and pleuraCervical lymph node dissection, targeted therapy (dabrafenib, anlotinib), multiple doses of 131IDeath due to respiratory failure3 moThewjitcharoen et al. [11]79/FHoarseness, neck massConventionalSquamous cell carcinomaCervical lymph nodesRadical neck dissection, high-dose radioactive iodine, external beam radiation, tracheostomyRecurrence18 moGhosh et al. [12]62/FPulmonary and mediastinal disease, and a peripancreatic massConventionalHigh-grade mucoepidermoid carcinoma with squamous, adenocarcinoma, and anaplastic carcinoma areasLung, mediastinal lymph nodes, peripancreatic regionDabrafenib and trametinibDeathN/AAbbreviations: F, female; M, male; N/A, not applicable; PTC, papillary thyroid carcinoma; TCV, tall cell variant. Review of papillary thyroid carcinoma transforming in metastatic sites. Abbreviations: F, female; M, male; N/A, not applicable; PTC, papillary thyroid carcinoma; TCV, tall cell variant. Dedifferentiation of PTC into SCC poses a considerable diagnostic challenge. Accurate diagnosis depends on thorough histopathological evaluation, complemented by immunohistochemical and molecular analyses [9]. For the first case, thyroid function tests, neck US, and computed tomography scans of the neck, chest, and abdomen were performed. US-guided FNA of a suspicious lymph node was obtained. HPE revealed metastatic PTC with squamous dedifferentiation in the right cervical lymph nodes, with no identifiable primary tumor in the thyroid gland. Immunohistochemistry confirmed thyroid origin, showing strong positivity for TTF-1 and PAX8. The differential diagnosis of squamous cell carcinoma within the thyroid includes primary squamous cell carcinoma, metastatic disease from head and neck malignancies, direct invasion from adjacent structures, and spindle cell squamous carcinoma, a variant of anaplastic thyroid carcinoma [11]. These possibilities were excluded based on detailed histopathological evaluation of the excised specimen. The discrepancy between the preoperative radiological findings, specifically the TIRADS 4 nodules (5×4×3 mm and 3×4×2 mm) and the CT description of an exophytic right thyroid primary, and the final histopathological report of "no identifiable primary tumor" presents a significant diagnostic challenge. Given that exhaustive serial sectioning of the entire thyroid gland was performed, the absence of an identifiable malignancy within the resected specimen is highly suggestive of an "occult" or "burnt-out" primary carcinoma. This scenario implies that the primary lesion was likely a microcarcinoma that was either completely obliterated by the sampling process or underwent a process of spontaneous regression, potentially replaced by fibrosis. Squamous dedifferentiation is reported to most commonly arise from conventional PTC [9]. Among the 5 reviewed cases of squamous dedifferentiation, 4 originated from conventional PTC, while 1 arose in the tall-cell variant. Because this transformation is rare, no standardized management protocol exists. Reported treatments have included surgical resection, chemotherapy, and radiation therapy, administered either alone or in combination [3,4,8,9,11]. Outcomes were generally poor; only 1 patient experienced symptomatic improvement without complications, while others developed recurrence, septic shock, or succumbed to the disease [3,8,9,11]. The first case underwent total thyroidectomy followed by radioiodine ablation and levothyroxine therapy (100 µg daily). Although initially disease-free, she developed multiple right-sided lymphadenopathies and liver metastases within 3 months, highlighting the highly aggressive nature of this tumor variant. She was subsequently referred to an oncologist and underwent 33 sessions of radiotherapy and 12 cycles of chemotherapy. Despite treatment, her condition progressed, with the development of lung metastases, and she died at the 7-month follow-up. Previously, DHGTC encompassed PTC, follicular thyroid carcinoma, or oncocytic carcinoma exhibiting high-grade features (≥ 5 mitoses per 2 mm², and/or the presence of tumor necrosis with no anaplastic features) [13] This newly recognized subtype differs from poorly differentiated thyroid carcinoma by maintaining a predominantly well-differentiated, follicular-derived architecture with characteristic nuclear features and growth patterns, while exhibiting a similarly intermediate clinical prognosis [13]. Poma et al. [5] stated that DHGTC is more prevalent in follicular thyroid carcinoma and some aggressive subtypes of PTC. Although present in less than 11% of tumors, aggressive high-grade features are clinically significant, even when they appear in only a small portion of the lesion [13]. Diagnosing DHGTC relies on macro and microscopic features, tumor necrosis, mitotic count, growth pattern, nuclear features, immunohistochemistry, and cytology. Macroscopically, DHGTC can form complete or partial encapsulation, progressing to gross infiltration and extrathyroidal extension [13]. An important differential of DHGTC is poorly differentiated thyroid carcinoma; it has a poorly differentiated growth pattern and absence of nuclear features of PTC [5]. High-grade features, defined by tumor necrosis and/or a high mitotic count, are strong negative prognostic indicators, with tumor necrosis being particularly significant. The necrosis associated with high-grade features is often referred to as “fresh,” “spontaneous,” “comedo,” or “true” tumor necrosis [14]. The growth pattern helps differentiate DHGTC from other tumors, as it retains predominantly well-differentiated follicular or papillary patterns, despite exhibiting high-grade features [13]. FNA has an important role in the initial evaluation of thyroid nodules. Tondi Resta et al. [15] reported cytological findings from 32 DHGTC cases, most of which were classified as Bethesda category VI (14 cases), which correlated well with prior surgical pathology diagnoses that predominantly indicated PTC. The second case was also classified as Bethesda VI category. Definitive diagnosis of DHGTC on cytology is challenging, as similar features may be seen in rare noninvasive tumors, and infarction can mimic true tumor necrosis. Nonetheless, the presence of such features on cytology should raise suspicion for DHGTC and prompt further diagnostic evaluation [13]. Aggressive management is required for DHGTC. Early-stage disease may be cured with surgery, while advanced cases often need adjuvant therapy. Total thyroidectomy with lymph node dissection is standard, but additional surgery may be required for local invasion. DHGTC is often radioiodine-refractory, so fluorodeoxyglucose positron emission tomography is preferred for follow-up, and optimal adjuvant therapy remains unclear [13]. Two cases of papillary thyroid carcinoma (PTC) with high-grade transformation were identified, both exhibiting transformation within the lungs, with 1 case also involving the peripancreatic region, both of which resulted in death [[10], [11], [12]]. The second case underwent total thyroidectomy with neck dissection followed by radioactive iodine ablation, and was maintained on levothyroxine 100 µg daily. She showed a favorable outcome and remained clinically well at her latest follow-up in March 2026. However, a longer follow-up is needed to determine the efficacy of her treatment. It is worth noting that this report has several limitations, including the lack of molecular data, a relatively short follow-up period, and incomplete oncologic outcome data for Patient 2. Conclusion Lymph node metastases originating from the thyroid may undergo histological transformation and exhibit aggressive behavior. Total thyroidectomy combined with radioiodine ablation and hormone therapy might yield favorable outcomes, but regional and distant metastases may still develop. Data availability statement Data regarding this study can be requested from the corresponding author. Declaration of generative AI and AI-assisted technologies in the writing process Declaration of generative AI and AI-assisted technologies in the manuscript preparation process: During the preparation of this work, the authors used ChatGPT to refine the language of the manuscript. After using this tool, the authors reviewed and edited the content as needed and take full responsibility for the content of the published article. Patient consent Written informed consent for publication was obtained from both patients.